-
EP1140212
European procedure
Extract from the Register of European Patents
EP About this file: EP1140212
| EP1140212 - THE USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN PALLIATION AND THERAPY OF BONE CANCER [Right-click to bookmark this link] | |||
| Former [2001/41] | THE PREPARATION AND USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN PALLIATION, BONE CANCER THERAPY, AND BONE SURFACE CONDITIONING | ||
| [2006/05] | Status | No opposition filed within time limit Status updated on 04.05.2007 Database last updated on 31.08.2024 | Most recent event Tooltip | 04.05.2007 | No opposition filed within time limit | published on 06.06.2007 [2007/23] | Applicant(s) | For all designated states Algeta AS Kjelsasveien 172A 0884 Oslo / NO | [2006/25] |
| Former [2001/41] | For all designated states Anticancer Therapeutic Inventions AS P.O. Box 96, Blindern 0314 Oslo / NO | Inventor(s) | 01 /
LARSEN, Roy, H. Furuveien 17a N-1340 Bekkestua / NO | 02 /
HENRIKSEN, Gjermund Hagatjernveien 32 N-3050 Mjondalen / NO | [2001/41] | Representative(s) | Cockbain, Julian Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | [N/P] |
| Former [2001/41] | Cockbain, Julian, Dr. Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street London EC4V 4EL / GB | Application number, filing date | 99960058.8 | 17.12.1999 | [2001/41] | WO1999NO00392 | Priority number, date | NO19990000001 | 04.01.1999 Original published format: NO 990001 | [2001/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0040275 | Date: | 13.07.2000 | Language: | EN | [2000/28] | Type: | A2 Application without search report | No.: | EP1140212 | Date: | 10.10.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.07.2000 takes the place of the publication of the European patent application. | [2001/41] | Type: | B1 Patent specification | No.: | EP1140212 | Date: | 28.06.2006 | Language: | EN | [2006/26] | Search report(s) | International search report - published on: | EP | 21.06.2001 | Classification | IPC: | A61K51/00, A61P19/08 | [2006/05] | CPC: |
A61K51/1282 (EP,US);
A61K51/00 (KR);
A61P19/00 (EP);
A61P19/08 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
|
| Former IPC [2001/41] | A61K51/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/41] | Extension states | AL | 03.08.2001 | LT | 03.08.2001 | LV | 03.08.2001 | MK | 03.08.2001 | RO | 03.08.2001 | SI | 03.08.2001 | Title | German: | ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS | [2006/05] | English: | THE USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN PALLIATION AND THERAPY OF BONE CANCER | [2006/05] | French: | UTILISATION DU RADIUM 223 POUR CIBLER DES TISSUS CALCIFIES A DES FINS DE TRAITEMENT PALLIATIF ET TRAITEMENT CONTRE LA DOULEUR DU CANCER DES OS | [2006/05] |
| Former [2001/41] | ANMELDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS | ||
| Former [2001/41] | THE PREPARATION AND USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN PALLIATION, BONE CANCER THERAPY, AND BONE SURFACE CONDITIONING | ||
| Former [2001/41] | PREPARATION ET UTILISATION DU RADIUM 223 POUR CIBLER DES TISSUS CALCIFIES A DES FINS DE TRAITEMENT PALLIATIF CONTRE LA DOULEUR, DE TRAITEMENT DU CANCER DES OS ET DE CONDITIONNEMENT DE SURFACES OSSEUSES | Entry into regional phase | 03.08.2001 | National basic fee paid | 03.08.2001 | Designation fee(s) paid | 03.08.2001 | Examination fee paid | Examination procedure | 13.07.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 03.08.2001 | Amendment by applicant (claims and/or description) | 03.08.2001 | Examination requested [2001/41] | 04.03.2004 | Despatch of a communication from the examining division (Time limit: M06) | 14.09.2004 | Reply to a communication from the examining division | 27.12.2005 | Communication of intention to grant the patent | 05.05.2006 | Fee for grant paid | 05.05.2006 | Fee for publishing/printing paid | Opposition(s) | 29.03.2007 | No opposition filed within time limit [2007/23] | Fees paid | Renewal fee | 27.12.2001 | Renewal fee patent year 03 | 27.12.2002 | Renewal fee patent year 04 | 19.12.2003 | Renewal fee patent year 05 | 27.12.2004 | Renewal fee patent year 06 | 21.12.2005 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9309816 (BATTELLE MEMORIAL INSTITUTE [US]) [X] 6-10,12,14-18 * claims 1,11,18,30 *; | [A]US5809394 (BRAY LANE A [US], et al) [A] 1-5 * column 1, line 20 - line 51 * * column 2, line 43 - line 52 * * column 4, line 38 - line 49 * * column 5, line 60 - column 6, line 44; figures 1,2 *; | [PX]WO9924081 (BATTELLE MEMORIAL INSTITUTE [US], et al) [PX] 6-10,12,14-18 * page 12, line 21 - page 13, line 16 *; | [X] - MCDEVITT M R ET AL, "Radioimmunotherapy with alpha-emitting nuclides", EUR J NUCL MED, (19980909), vol. 25, no. 9, pages 1341 - 1351, XP002901567 [X] 6-10,12,14-18 * page 1341 * * page 1345 * DOI: http://dx.doi.org/10.1007/s002590050306 | [X] - HOWELL R W ET AL, "Radiotoxicity of Gadolinium-148 and Radium-223 in Mouse Testes: Relative Biological Effectiveness of Alpha-Particle Emitters In Vivo", RADIATION RESEARCH, (1997), vol. 147, pages 342 - 348, XP002901568 [X] 6-10,12,14-18 * abstract, introduction and conclusions * | [A] - JIN XIAO-HAI, "Development of the Radiopharmaceuticals for Interventional Tumor Therapy in China", J OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, ARTICLES, (1996), vol. 206, no. 1, pages 17 - 27, XP002901569 [A] 6-18 * "Clinical applications" section 2, pages 21-22 * DOI: http://dx.doi.org/10.1007/BF02040037 |